Furthermore, the acquired heart problems mediated by systemic inflammation such as tumor necrosis factor-α and PD-1/PDL-1 inhibitors may exaggerate or accelerate the decompensation of pre-existing heart diseases (heart failure, arrhythmia, heart injury, and dysfunction) in susceptible individuals. Here, CD274 is linked to heart failure.